Follow the 프롬바이오 share price and the full directors' dealings record of the company, a listed equity based in South Korea. Shares are quoted on KR KR, under the oversight of DART (FSS). Operating in the Health Care sector, 프롬바이오 has recorded 30 public disclosures. The latest transaction was filed on 2 July 2026 (Purchase). Among the most active insiders: 심태진. The full history is free.
30
Insider Decl.
n/a
Thresholds
n/a
17 ops.
Buy Volume
n/a
n/a
Sell Volume
22Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.